CoChat

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal

Open access
James, Kieran, Bottacini, Francesca, Contreras, Jose Ivan Serrano, Vigoureux, Mariane, Egan, Muireann, Motherway, Mary O’connell, Holmes, Elaine, van Sinderen, Douwe · 2019 · Scientific Reports
Cited by 78

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

A number of bifidobacterial species are found at a particularly high prevalence and abundance in faecal samples of healthy breastfed infants, a phenomenon that is believed to be, at least partially, due to the ability of bifidobacteria to metabolize H uman M ilk O ligosaccharides (HMOs). In the current study, we isolated a novel strain of Bifidobacterium kashiwanohense, named APCKJ1, from the faeces of a four-week old breastfed infant, based on the ability of the strain to utilise the HMO component fucosyllactose. We then determined the full genome sequence of this strain, and employed the generated data to analyze fucosyllactose metabolism in B. kashiwanohense APCKJ1. Transcriptomic and growth analyses, combined with metabolite analysis, in vitro hydrolysis assays and heterologous expression, allowed us to elucidate the pathway for fucosyllactose metabolism in B. kashiwanohense APCKJ1. Homologs of the key genes for this metabolic pathway were identified in particular in infant-derived members of the Bifdobacterium genus, revealing the apparent niche-specific nature of this pathway, and allowing a broad perspective on bifidobacterial fucosyllactose and L-fucose metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-51901-7

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 80

  1. Engfer, M. B., Stahl, B., Finke, B., Sawatzki, G. & Daniel, H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 71, 1589–1596 (2000). · DOI · Paper page
  2. Kunz, C., Rudloff, S., Baier, W., Klein, N. & Strobel, S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annual review of nutrition 20, 699–722, https://doi.org/10.1146/annurev.nutr.20.1.699 (2000). · DOI · Paper page
  3. Brussow, H. Human microbiota: ‘the philosophers have only interpreted the world in various ways. The point, however, is to change it’. Microbial biotechnology 8, 11–12, https://doi.org/10.1111/1751-7915.12259 (2015). · DOI
  4. Bezirtzoglou, E., Tsiotsias, A. & Welling, G. W. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17, 478–482, https://doi.org/10.1016/j.anaerobe.2011.03.009 (2011). · DOI · Paper page
  5. Wang, M. et al. Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. Journal of pediatric gastroenterology and nutrition 60, 825–833, https://doi.org/10.1097/MPG.0000000000000752 (2015). · DOI · Paper page
  6. Asakuma, S. et al. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. The Journal of biological chemistry 286, 34583–34592, https://doi.org/10.1074/jbc.M111.248138 (2011). · DOI · Paper page
  7. Sela, D. A. Bifidobacterial utilization of human milk oligosaccharides. International journal of food microbiology 149, 58–64, https://doi.org/10.1016/j.ijfoodmicro.2011.01.025 (2011). · DOI
  8. Gibson, G. R. & Roberfroid, M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. The Journal of nutrition 125, 1401–1412 (1995). · DOI · Paper page
  9. Bode, L. Human Milk Oligosaccharides at the Interface of Maternal-Infant Health. Breastfeeding medicine: the official journal of the Academy of Breastfeeding Medicine 13, S7–s8, https://doi.org/10.1089/bfm.2018.29073.ljb (2018). · DOI
  10. Bottacini, F., van Sinderen, D. & Ventura, M. Omics of bifidobacteria: research and insights into their health-promoting activities. The Biochemical journal 474, 4137–4152, https://doi.org/10.1042/BCJ20160756 (2017). · DOI · Paper page
  11. Simone, M. et al. The probiotic Bifidobacterium breve B632 inhibited the growth of Enterobacteriaceae within colicky infant microbiota cultures. BioMed research international 2014, 301053, https://doi.org/10.1155/2014/301053 (2014). · DOI
  12. Di Gioia, D., Aloisio, I., Mazzola, G. & Biavati, B. Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants. Applied microbiology and biotechnology 98, 563–577, https://doi.org/10.1007/s00253-013-5405-9 (2014). · DOI · Paper page
  13. Ward, R. E., Ninonuevo, M., Mills, D. A., Lebrilla, C. B. & German, J. B. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res 51, 1398–1405, https://doi.org/10.1002/mnfr.200700150 (2007). · DOI · Paper page
  14. Kitaoka, M. Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Advances in nutrition (Bethesda, Md.) 3, 422s–429s, https://doi.org/10.3945/an.111.001420 (2012). · DOI
  15. Wada, J. et al. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Applied and environmental microbiology 74, 3996–4004, https://doi.org/10.1128/aem.00149-08 (2008). · DOI · Paper page
  16. Moller, P. L., Jorgensen, F., Hansen, O. C., Madsen, S. M. & Stougaard, P. Intra- and extracellular beta-galactosidases from Bifidobacterium bifidum and B. infantis: molecular cloning, heterologous expression, and comparative characterization. Applied and environmental microbiology 67, 2276–2283, https://doi.org/10.1128/aem.67.5.2276-2283.2001 (2001). · DOI
  17. Sakurama, H. et al. Lacto-N-biosidase encoded by a novel gene of Bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression. The Journal of biological chemistry 288, 25194–25206, https://doi.org/10.1074/jbc.M113.484733 (2013). · DOI · Paper page
  18. Miwa, M. et al. Cooperation of beta-galactosidase and beta-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 20, 1402–1409, https://doi.org/10.1093/glycob/cwq101 (2010). · DOI · Paper page
  19. Ashida, H. et al. Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19, 1010–1017, https://doi.org/10.1093/glycob/cwp082 (2009). · DOI · Paper page
  20. Kiyohara, M. et al. An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates. Glycobiology 21, 437–447, https://doi.org/10.1093/glycob/cwq175 (2011). · DOI · Paper page
  21. Sela, D. A. et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci USA 105, 18964–18969, https://doi.org/10.1073/pnas.0809584105 (2008). · DOI · Paper page
  22. Yoshida, E. et al. Bifidobacterium longum subsp. infantis uses two different beta-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 22, 361–368, https://doi.org/10.1093/glycob/cwr116 (2012). · DOI · Paper page
  23. Garrido, D., Ruiz-Moyano, S. & Mills, D. A. Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. Anaerobe 18, 430–435, https://doi.org/10.1016/j.anaerobe.2012.04.012 (2012). · DOI · Paper page
  24. Xiao, J. Z. et al. Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Applied and environmental microbiology 76, 54–59, https://doi.org/10.1128/aem.01683-09 (2010). · DOI · Paper page
  25. James, K., Motherway, M. O., Bottacini, F. & van Sinderen, D. Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways. Scientific reports 6, 38560, https://doi.org/10.1038/srep38560 (2016). · DOI · Paper page
  26. Sela, D. A. et al. Bifidobacterium longum subsp. infantis ATCC 15697 alpha-fucosidases are active on fucosylated human milk oligosaccharides. Applied and environmental microbiology 78, 795–803, https://doi.org/10.1128/AEM.06762-11 (2012). · DOI · Paper page
  27. Bunesova, V., Lacroix, C. & Schwab, C. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense. BMC microbiology 16, 248, https://doi.org/10.1186/s12866-016-0867-4 (2016). · DOI · Paper page
  28. Vazquez-Gutierrez, P. et al. Bifidobacteria strains isolated from stools of iron deficient infants can efficiently sequester iron. BMC microbiology 15, 3, https://doi.org/10.1186/s12866-014-0334-z (2015). · DOI · Paper page
  29. Morita, H. et al. Bifidobacterium kashiwanohense sp. nov., isolated from healthy infant faeces. International journal of systematic and evolutionary microbiology 61, 2610–2615, https://doi.org/10.1099/ijs.0.024521-0 (2011). · DOI
  30. McGuire, M. K. et al. What’s normal? Oligosaccharide concentrations and profiles in milk produced by healthy women vary geographically. The American journal of clinical nutrition 105, 1086–1100, https://doi.org/10.3945/ajcn.116.139980 (2017). · DOI · Paper page
  31. Matsuki, T. et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nature communications 7, 11939, https://doi.org/10.1038/ncomms11939 (2016). · DOI · Paper page
  32. Schwab, C. et al. Trophic Interactions of Infant Bifidobacteria and Eubacterium hallii during L-Fucose and Fucosyllactose Degradation. Front Microbiol 8, 95, https://doi.org/10.3389/fmicb.2017.00095 (2017). · DOI · Paper page
  33. Rada, V. Detection of Bifidobacterium species by enzymatic methods and antimicrobial susceptibility testing. Biotechnology Techniques 11, 909–912 (1997). · DOI
  34. Simpson, P. J., Fitzgerald, G. F., Stanton, C. & Ross, R. P. The evaluation of a mupirocin-based selective medium for the enumeration of bifidobacteria from probiotic animal feed. Journal of microbiological methods 57, 9–16, https://doi.org/10.1016/j.mimet.2003.11.010 (2004). · DOI
  35. Pokusaeva, K., Fitzgerald, G. F. & van Sinderen, D. Carbohydrate metabolism in Bifidobacteria. Genes &. nutrition 6, 285–306, https://doi.org/10.1007/s12263-010-0206-6 (2011). · DOI · Paper page
  36. Sela, D. A. et al. Bifidobacterium longum subsp. infantis ATCC 15697 α-Fucosidases Are Active on Fucosylated Human Milk Oligosaccharides. Applied and environmental microbiology 78, 795–803, https://doi.org/10.1128/AEM.06762-11 (2012). · DOI · Paper page
  37. Katayama, T. et al. Molecular cloning and characterization of Bifidobacterium bifidum 1,2-alpha-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). Journal of bacteriology 186, 4885–4893, https://doi.org/10.1128/jb.186.15.4885-4893.2004 (2004). · DOI · Paper page
  38. Fan, S. et al. Cloning, characterization, and production of three alpha-L-fucosidases from Clostridium perfringens ATCC 13124. Journal of basic microbiology 56, 347–357, https://doi.org/10.1002/jobm.201500582 (2016). · DOI · Paper page
  39. Lammerts van Bueren, A., Popat, S. D., Lin, C. H. & Davies, G. J. Structural and thermodynamic analyses of alpha-L-fucosidase inhibitors. Chembiochem: a European journal of chemical biology 11, 1971–1974, https://doi.org/10.1002/cbic.201000339 (2010). · doi:10.1002/cbic.201000339
  40. Sakurama, H. et al. Differences in the substrate specificities and active-site structures of two alpha-L-fucosidases (glycoside hydrolase family 29) from Bacteroides thetaiotaomicron. Bioscience, biotechnology, and biochemistry 76, 1022–1024, https://doi.org/10.1271/bbb.111004 (2012). · DOI
  41. Guillotin, L., Lafite, P. & Daniellou, R. Unraveling the substrate recognition mechanism and specificity of the unusual glycosyl hydrolase family 29 BT2192 from Bacteroides thetaiotaomicron. Biochemistry 53, 1447–1455, https://doi.org/10.1021/bi400951q (2014). · DOI
  42. Sulzenbacher, G. et al. Crystal structure of Thermotoga maritima alpha-L-fucosidase. Insights into the catalytic mechanism and the molecular basis for fucosidosis. The Journal of biological chemistry 279, 13119–13128, https://doi.org/10.1074/jbc.M313783200 (2004). · DOI · Paper page
  43. Egan, M. et al. Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC microbiology 14, 282, https://doi.org/10.1186/s12866-014-0282-7 (2014). · DOI · Paper page
  44. Ruiz-Moyano, S. et al. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Applied and environmental microbiology 79, 6040–6049, https://doi.org/10.1128/AEM.01843-13 (2013). · DOI · Paper page
  45. O’Connell Motherway, M., Kinsella, M., Fitzgerald, G. F. & van Sinderen, D. Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003. Microb Biotechnol 6, 67–79, https://doi.org/10.1111/1751-7915.12011 (2013). · DOI
  46. Yew, W. S. et al. Evolution of enzymatic activities in the enolase superfamily: L-fuconate dehydratase from Xanthomonas campestris. Biochemistry 45, 14582–14597, https://doi.org/10.1021/bi061687o (2006). · DOI
  47. Turroni, F. et al. Analysis of predicted carbohydrate transport systems encoded by Bifidobacterium bifidum PRL2010. Applied and environmental microbiology 78, 5002–5012, https://doi.org/10.1128/AEM.00629-12 (2012). · DOI · Paper page
  48. Khoroshkin, M. S., Leyn, S. A., Van Sinderen, D. & Rodionov, D. A. Transcriptional Regulation of Carbohydrate Utilization Pathways in the Bifidobacterium Genus. Front Microbiol 7, 120, https://doi.org/10.3389/fmicb.2016.00120 (2016). · DOI
  49. Turroni, F. et al. Bifidobacterium bifidum as an example of a specialized human gut commensal. Front Microbiol 5, 437, https://doi.org/10.3389/fmicb.2014.00437 (2014). · DOI · Paper page
  50. Benno, Y., Sawada, K. & Mitsuoka, T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiology and immunology 28, 975–986 (1984). · DOI · Paper page
  51. Guaraldi, F. & Salvatori, G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Frontiers in cellular and infection microbiology 2, 94, https://doi.org/10.3389/fcimb.2012.00094 (2012). · DOI · Paper page
  52. Garrido, D. et al. A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596. Scientific reports 6, 35045, https://doi.org/10.1038/srep35045 (2016). · DOI · Paper page
  53. Casazza, J. P., Song, B. J. & Veech, R. L. Short chain diol metabolism in human disease states. Trends in biochemical sciences 15, 26–30 (1990). · DOI
  54. Jackson, F. Metabolic phenotyping and metagenomic analysis of developing infants. Doctor of Philosophy (PhD) thesis, Imperial College London (2016).
  55. Watson, D. et al. Selective carbohydrate utilization by lactobacilli and bifidobacteria. Journal of applied microbiology 114, 1132–1146, https://doi.org/10.1111/jam.12105 (2013). · DOI · Paper page
  56. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J Mol Biol 215, 403–410, https://doi.org/10.1016/s0022-2836(05)80360-2 (1990). · doi:10.1016/s0022-2836(05)80360-2 · Paper page
  57. Lagesen, K. et al. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic acids research 35, 3100–3108, https://doi.org/10.1093/nar/gkm160 (2007). · DOI · Paper page
  58. Rutherford, K. et al. Artemis: sequence visualization and annotation. Bioinformatics 16, 944–945 (2000). · DOI · Paper page
  59. Morita, H. et al. Complete Genome Sequence of Bifidobacterium kashiwanohense JCM 15439 T, Isolated from Feces from a Healthy Japanese Infant. Genome announcements 3, https://doi.org/10.1128/genomeA.00255-15 (2015). · DOI
  60. Vazquez-Gutierrez, P. et al. Complete and Assembled Genome Sequence of Bifidobacterium kashiwanohense PV20-2, Isolated from the Feces of an Anemic Kenyan Infant. Genome announcements 3, https://doi.org/10.1128/genomeA.01467-14 (2015). · doi:10.1128/genomea.01467-14
  61. Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Molecular systems biology 7, 539, https://doi.org/10.1038/msb.2011.75 (2011). · DOI · Paper page
  62. Terzaghi, B. E. & Sandine, W. E. Improved medium for lactic streptococci and their bacteriophages. Appl Microbiol 29, 807–813 (1975). · doi:10.1128/aem.29.6.807-813.1975 · Paper page
  63. Sambrook, J. F. E. & Maniatis, T. Molecular cloning: a laboratory manual, 2nd ed., (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989).
  64. Zomer, A. et al. An interactive regulatory network controls stress response in Bifidobacterium breve UCC2003. Journal of bacteriology 191, 7039–7049, https://doi.org/10.1128/jb.00897-09 (2009). · DOI · Paper page
  65. Garcia de la Nava, J. et al. Engene: the processing and exploratory analysis of gene expression data. Bioinformatics 19, 657–658 (2003). · DOI
  66. van Hijum, S. A. et al. A generally applicable validation scheme for the assessment of factors involved in reproducibility and quality of DNA-microarray data. BMC genomics 6, 77, https://doi.org/10.1186/1471-2164-6-77 (2005). · DOI · Paper page
  67. Long, A. D. et al. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. The Journal of biological chemistry 276, 19937–19944, https://doi.org/10.1074/jbc.M010192200 (2001). · DOI · Paper page
  68. O’Riordan, K. & Fitzgerald, G. F. Evaluation of bifidobacteria for the production of antimicrobial compounds and assessment of performance in cottage cheese at refrigeration temperatur. e. Journal of applied microbiology 85, 103–114 (1998). · DOI · Paper page
  69. O’Connell Motherway, M., O’Driscoll, J., Fitzgerald, G. F. & Van Sinderen, D. Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in Bifidobacterium breve UCC2003. Microb Biotechnol 2, 321–332, https://doi.org/10.1111/j.1751-7915.2008.00071.x (2009). · DOI · Paper page
  70. Law, J. et al. A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. Journal of bacteriology 177, 7011–7018 (1995). · DOI · Paper page
  71. Mierau, I. & Kleerebezem, M. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Applied microbiology and biotechnology 68, 705–717, https://doi.org/10.1007/s00253-005-0107-6 (2005). · DOI · Paper page
  72. O’Connell, K. J. et al. Metabolism of four alpha-glycosidic linkage-containing oligosaccharides by Bifidobacterium breve UCC2003. Applied and environmental microbiology 79, 6280–6292, https://doi.org/10.1128/aem.01775-13 (2013). · DOI · Paper page
  73. O’Connell Motherway, M., Fitzgerald, G. F. & van Sinderen, D. Metabolism of a plant derived galactose-containing polysaccharide by Bifidobacterium breve UCC2003. Microbial biotechnology 4, 403–416, https://doi.org/10.1111/j.1751-7915.2010.00218.x (2011). · DOI · Paper page
  74. Pokusaeva, K. et al. Cellodextrin utilization by bifidobacterium breve UCC2003. Applied and environmental microbiology 77, 1681–1690, https://doi.org/10.1128/aem.01786-10 (2011). · DOI
  75. de Ruyter, P. G., Kuipers, O. P. & de Vos, W. M. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Applied and environmental microbiology 62, 3662–3667 (1996). · DOI · Paper page
  76. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry 72, 248–254 (1976). · DOI · Paper page
  77. Bottacini, F. et al. Comparative genomics and genotype-phenotype associations in Bifidobacterium breve. Scientific reports 8, 10633, https://doi.org/10.1038/s41598-018-28919-4 (2018). · DOI
  78. Dieterle, F., Ross, A., Schlotterbeck, G. & Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1 H NMR metabonomics. Analytical chemistry 78, 4281–4290, https://doi.org/10.1021/ac051632c (2006). · DOI · Paper page
  79. Enright, A. J., Van Dongen, S. & Ouzounis, C. A. An efficient algorithm for large-scale detection of protein families. Nucleic acids research 30, 1575–1584 (2002). · DOI · Paper page
  80. James, K. Metabolism of human milk oligosaccharides by infant-associated bifidobacteria. Doctorate of Philosophy (PhD) thesis, University College Cork (2018).

Cited by

See all 78

Metadata

Authors
James, K., Bottacini, F., Contreras, J. I. S., Vigoureux, M., Egan, M., Motherway, M. O., Holmes, E., & van Sinderen, D.
Venue
Scientific Reports
Published
2019-10-28
Volume
9
Issue
1
Pages
15427-15427
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2981761689
Cited by
78
References
15
FWCI
7.80
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Irish Research Council for Science, Engineering and Technology (GOIPG/2013/651)
  • Federation of European Microbiological Societies (FEMS-RG-2016-0103)
  • DH | National Institute for Health Research (BRC Gut Health Theme)
  • Science Foundation Ireland (SFI/12/RC/2273)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal. https://app.cochat.ai/papers/10.1038/s41598-019-51901-7
The paper
James, K., Bottacini, F., Contreras, J. I. S., Vigoureux, M., Egan, M., Motherway, M. O., Holmes, E., & van Sinderen, D. (2019). Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal. Scientific Reports. https://doi.org/10.1038/s41598-019-51901-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.